Outsource high-potency ADC manufacturing to specialized CDMOs to reduce capital investment, access containment infrastructure, and accelerate clinical-to-commercial scale-up.Dublin, Oct. (GLOBE ...
Fox Rothschild's Mark Wagner on why scaling drug production is so slow — overseas API sourcing, supplier qualification, and ...
Medical cannabis active pharmaceutical ingredient manufacturer NeoCannBio signed a memorandum of understanding on October 12, ...
SHELTON, CT / ACCESS Newswire / October 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Critical Manufacturing Milestone Supports Supply Chain Readiness and Planned Phase 2b Clinical Trial Initiation in First Quarter 2027King of Prussia, Pennsylvania--(Newsfile Corp. -) - Phio ...
The Chosun Ilbo on MSN
Novo Nordisk's future factory automates full Wegovy production
On October 2, local time, at a bio factory located in Hillerød, approximately 40 km north of Copenhagen, the capital of ...
Google is rolling out Gemini 4 Argon and offering 10,000 scientists six months of free Google Antigravity access, subject to ...
Fish Audio's open-weight Drama 3 TTS model tops ElevenLabs on pronunciation accuracy and is free under $500K revenue, per ...
14hon MSN
EU advances Ukraine accession as Hungary lifts veto, paving way for Zelenskyy-Magyar meeting
Ukraine's President Volodymyr Zelenskyy, right, greets Hungary's Prime Minister Peter Magyar, center, next to European ...
HarbinPharmaceutical (SHA:600664) subsidiary Harbin Pharmaceutical Group Bioengineering obtained a drug registration approval ...
IMCIVREE was commercially launched in Japan on October 13, 2026, after receiving MHLW approval. IMCIVREE is an MC4R agonist ...
TRexBio successfully closed its initial public offering, raising approximately $116.7 million, which provides significant funding for its clinical-stage biotechnology initiatives. The company's common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results